Generics Russia, together with Arabian investors, are finishing building of a new pharmaceutical factory in Syria, that will specialize on the manufacture of anti-cancer drugs and will be the largest production facility of its kind in the entire Middle East region, according to recent statements of investors and some local analysts in the field of pharmaceutics, reports The Pharma Letter’s local correspondent. 7 January 2020